![Solomon Langermann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Solomon Langermann
Direttore/Membro del Consiglio presso
Verimmune, Inc.
Profilo
Solomon Langermann currently works at Verimmune, Inc., as Director.
Dr. Langermann also formerly worked at MedImmune LLC, as Director-Immunology & Molecular Genetics, PharmAthene, Inc., as Chief Scientific Officer & Vice President from 2004 to 2007, Amplimmune, Inc., as Chief Scientific Officer & Senior Vice President from 2013 to 2015, the University of Maryland, as Principal, PharmAthene, Inc., as Chief Scientific Officer & Vice President from 2004 to 2007, and NextCure, Inc., as Chief Scientific Officer from 2018 to 2025.
Dr. Langermann received his graduate degree from Harvard University, doctorate degree from Tufts University, and undergraduate degree from Columbia College (New York).
Posizioni attive di Solomon Langermann
| Società | Posizione | Inizio |
|---|---|---|
Verimmune, Inc.
 Verimmune, Inc. BiotechnologyHealth Technology Specializes in development of anti-tumor immune redirection therapy targeting cancer using pre-existing immune memory | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Solomon Langermann
| Società | Posizione | Fine |
|---|---|---|
| NEXTCURE, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2025 |
Amplimmune, Inc.
 Amplimmune, Inc. BiotechnologyHealth Technology Develops immune-based biological treatments | Direttore Tecnico/Scientifico/R&S | 01/07/2015 |
PharmAthene, Inc. /Old/
 PharmAthene, Inc. /Old/ BiotechnologyHealth Technology Develops biotherapeutics to address biological pathogens and chemicals | Direttore Tecnico/Scientifico/R&S | 09/08/2007 |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Direttore Tecnico/Scientifico/R&S | 01/01/2007 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | - |
Formazione di Solomon Langermann
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
55
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology Develops biotherapeutics to address biological pathogens and chemicals | Health Technology |
Amplimmune, Inc.
Amplimmune, Inc. BiotechnologyHealth Technology Develops immune-based biological treatments | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Health Technology |
Columbia College (New York)
 Columbia College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Verimmune, Inc.
Verimmune, Inc. BiotechnologyHealth Technology Specializes in development of anti-tumor immune redirection therapy targeting cancer using pre-existing immune memory | Health Technology |
